
The Match Out: Shares across the region struggle, Lithium hit by BofA
Here’s today’s The Match Out report from Market Matters’ James
Rask Media > Telix Pharmaceuticals Ltd (ASX:TLX) > Page 2

Here’s today’s The Match Out report from Market Matters’ James

Damian Cottier dives into why and how ASX investors can
Owen Rask and Drew Meredith are back on The Australian

A strong lead-in from Wall Street gave solid impetus to

The S&P/ASX 200 (ASX: XJO) gained another 0.3% to finish

The S&P/ASX 200 (ASX:XJO) delivered another positive day despite the

The S&P/ASX 200 (ASX: XJO) finished up another 0.3% on

Telix Pharmaceuticals Ltd (ASX: TLX) shares continue its upward trajectory,

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is sliding
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
By downloading, you agree to receive emails from us. You can unsubscribe anytime.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.